Safe and Fast Radial Hemostasis Using Synergistic Strategies: SAFE & FAST Trial
NCT06549842 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 451
Last updated 2026-03-03
Summary
The Safe and Fast Radial Hemostasis using Synergistic Strategies (SAFE \& FAST) trial is an interventional study aimed at reducing the incidence of radial artery occlusion (RAO) rebound bleeding, and the required compression time after transradial approach (TRA) procedures, which have become the default access for coronary procedures globally. The hypothesis is that combining lower-dose heparin and radial hemostasis with simultaneous ipsilateral ulnar artery compression could achieve these improved outcomes.
Conditions
- Cardiovascular Diseases
- Bleeding
- Arterial Puncture
- Catheter Complications
- Occlusion of Artery
Interventions
- DRUG
-
Heparin
The intervention for this study is the dose of heparin. Patients randomized to group 1 will receive a heparin dose of 50U/kg and those in group 2 will receive a lower dose of heparin at 25U/kg. Recovery period for group 1 would be 2 hours whereas for group 2 would be 1 hour.
- DEVICE
-
Terumo Radial Band
Group 1 will receive TR band post cardiac catheterization for radial hemostasis.
- DEVICE
-
Vaosband
Group 2 will receive Vasoband post cardiac catheterization for radial hemostasis.
Sponsors & Collaborators
-
Regional Hospital of Scranton
lead OTHER
Principal Investigators
-
Nishant Sethi, MD · Regional Hospital of Scranton
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-15
- Primary Completion
- 2026-02-15
- Completion
- 2026-02-20
- FDA Device
- Yes
Countries
- United States
- India
Study Locations
More Related Trials
-
Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical Patients
NCT00912483 ·Status: WITHDRAWN ·Phase: PHASE3
-
Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation
NCT01006876 ·Status: COMPLETED ·Phase: PHASE3
-
Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS)
NCT02024230 ·Status: COMPLETED ·Phase: PHASE4
-
The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma
NCT01050153 ·Status: COMPLETED ·Phase: NA
-
Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy
NCT06293287 ·Status: RECRUITING ·Phase: PHASE2
-
Standard vs High Dose of Unfractionated Heparin in the Incidence of Radial Artery Occlusion (DEFINITION) Trial.
NCT04561648 ·Status: RECRUITING ·Phase: NA
-
Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in China
NCT00781378 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Thrombolysis in Combination With Endhole Aspiration in the Treatment of Acute DVT
NCT04297787 ·Status: COMPLETED ·Phase: NA
-
Tinzaparin in the Treatment of the Acute Pulmonary Embolism
NCT00711308 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Heparin on Femoral Arterial Sheaths Thrombosis During Diagnostic Coronary Angiography
NCT01260519 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients
NCT00521885 ·Status: TERMINATED ·Phase: NA
-
Treatment for Blood Clots in the Veins of the Legs
NCT00001713 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)
NCT00443053 ·Status: COMPLETED ·Phase: PHASE3
-
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
NCT06957366 ·Status: RECRUITING ·Phase: NA
-
A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery
NCT00260988 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Rivaroxaban in Endovenous Laser Ablation With and Without Miniphlebectomy
NCT02584842 ·Status: COMPLETED
-
Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Subcutaneous Administration
NCT05788913 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluation of Wound Drainage After Knee or Hip Arthroplasty
NCT02054936 ·Status: WITHDRAWN ·Phase: PHASE4
-
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
NCT04862468 ·Status: RECRUITING ·Phase: PHASE2
-
Resolution of Left Atrial-Appendage Thrombus - Effects of Dabigatran in Patients With AF
NCT02256683 ·Status: TERMINATED ·Phase: PHASE2
-
Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD
NCT01531829 ·Status: UNKNOWN ·Phase: PHASE4
-
Intra-Arterial Tenecteplase to Improve the Microvascular Hemodynamics After Mechanical Thrombectomy
NCT06904911 ·Status: RECRUITING ·Phase: PHASE2
-
Catheter-interventional Treatment of Pulmonary Embolism
NCT05456789 ·Status: COMPLETED ·Phase: NA
-
Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation
NCT00621491 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Intravenous Administration
NCT05788900 ·Status: UNKNOWN ·Phase: PHASE1